Logos Global Management LP Q1 2021 Filing
Filed May 17, 2021
Portfolio Value
$1.0T
Holdings
53
Report Date
Q1 2021
Filing Type
13F-HR
All Holdings (53 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | ALXOALX ONCOLOGY HLDGS INC | 3,156,981 | $232.8B | 22.72% | |
| 2 | OLMAOLEMA PHARMACEUTICALS INC | 3,743,875 | $124.2B | 12.12% | |
| 3 | DSGNDESIGN THERAPEUTICS INC | 2,732,501 | $81.7B | 7.97% | |
| 4 | DYNDYNE THERAPEUTICS INC | 3,204,392 | $49.8B | 4.86% | |
| 5 | TILINSTIL BIO INC | 1,846,850 | $46.3B | 4.52% | |
| 6 | NKTXNKARTA INC | 1,260,877 | $41.5B | 4.05% | |
| 7 | —FORMA THERAPEUTICS HLDGS INC | 1,410,000 | $39.5B | 3.86% | |
| 8 | EWTXEDGEWISE THERAPEUTICS INC | 1,056,812 | $34.3B | 3.35% | |
| 9 | —KINNATE BIOPHARMA INC | 934,602 | $29.1B | 2.84% | |
| 10 | RPTXREPARE THERAPEUTICS INC | 900,000 | $27.6B | 2.70% | |
| 11 | KRTXKARUNA THERAPEUTICS INC | 200,000 | $24.0B | 2.35% | |
| 12 | BCYCBICYCLE THERAPEUTICS PLC | 800,000 | $23.9B | 2.33% | |
| 13 | —ATHIRA PHARMA INC | 1,010,812 | $18.6B | 1.82% | |
| 14 | BTAIEURBIOXCEL THERAPEUTICS INC | 400,000 | $17.3B | 1.68% | |
| 15 | CGEMCULLINAN ONCOLOGY INC | 413,458 | $17.2B | 1.68% | |
| 16 | CYTKCYTOKINETICS INC | 700,000 | $16.3B | 1.59% | |
| 17 | —TURNING POINT THERAPEUTICS I | 140,000 | $13.2B | 1.29% | |
| 18 | COGTUNUM THERAPEUTICS INC | 1,420,500 | $12.5B | 1.22% | |
| 19 | —IKENA ONCOLOGY INC | 419,853 | $11.9B | 1.16% | |
| 20 | ALGSALIGOS THERAPEUTICS INC | 476,547 | $10.8B | 1.06% | |
| 21 | KYMRKYMERA THERAPEUTICS INC | 260,920 | $10.1B | 0.99% | |
| 22 | —VINCERX PHARMA INC | 480,000 | $9.3B | 0.90% | |
| 23 | CMPSCOMPASS PATHWAYS PLC | 250,000 | $9.2B | 0.90% | |
| 24 | VRDNVIRIDIAN THERAPEUTICS INC | 550,000 | $9.2B | 0.90% | |
| 25 | —ASLAN PHARMACEUTICALS LTD | 2,300,000 | $7.7B | 0.75% | |
| 26 | OPHTEURIVERIC BIO INC | 1,200,000 | $7.4B | 0.72% | |
| 27 | KNSAKINIKSA PHARMACEUTICALS LTD | 400,000 | $7.4B | 0.72% | |
| 28 | —LANDOS BIOPHARMA INC | 734,000 | $7.1B | 0.69% | |
| 29 | PMVPPMV PHARMACEUTICALS INC | 200,000 | $6.6B | 0.64% | |
| 30 | —HARPOON THERAPEUTICS INC | 300,000 | $6.3B | 0.61% | |
| 31 | SPRYSILVERBACK THERAPEUTICS INC | 125,000 | $5.5B | 0.53% | |
| 32 | —THERAPEUTICS ACQUISITION COR | 500,000 | $5.3B | 0.51% | |
| 33 | BOLT1EURBOLT BIOTHERAPEUTICS INC | 150,000 | $4.9B | 0.48% | |
| 34 | KZRKEZAR LIFE SCIENCES INC | 800,000 | $4.8B | 0.47% | |
| 35 | ANNXANNEXON INC | 159,622 | $4.4B | 0.43% | |
| 36 | RYIVIRACTA THERAPEUTICS INC | 470,000 | $4.3B | 0.42% | |
| 37 | CCCCC4 THERAPEUTICS INC | 112,928 | $4.2B | 0.41% | |
| 38 | LRMRLARIMAR THERAPEUTICS INC | 230,000 | $3.4B | 0.33% | |
| 39 | —HEALTH SCIENCES ACQ CORP 2 | 300,000 | $3.4B | 0.33% | |
| 40 | HRMYHARMONY BIOSCIENCES HLDGS IN | 100,000 | $3.3B | 0.32% | |
| 41 | —RESEARCH ALLIANCE CORP II | 300,000 | $3.1B | 0.30% | |
| 42 | —LUCIRA HEALTH INC | 250,000 | $3.0B | 0.30% | |
| 43 | —FS DEVELOPMENT CORP II | 300,000 | $3.0B | 0.29% | |
| 44 | DCPHEURDECIPHERA PHARMACEUTICALS IN | 62,000 | $2.8B | 0.27% | |
| 45 | CNTBCONNECT BIOPHARMA HLDGS LTD | 150,000 | $2.8B | 0.27% | |
| 46 | —EARGO INC | 50,000 | $2.5B | 0.24% | |
| 47 | ELDNELEDON PHARMACEUTICALS INC | 224,071 | $2.4B | 0.23% | |
| 48 | —BCTG ACQUISITION CORP | 200,000 | $2.2B | 0.22% | |
| 49 | PASGPASSAGE BIO INC | 125,010 | $2.2B | 0.21% | |
| 50 | —ARYA SCIENCES ACQU CORP IV | 200,000 | $2.1B | 0.20% | |
| 51 | MLTXHELIX ACQUISITION CORP | 200,000 | $2.0B | 0.20% | |
| 52 | NUVB/WSNUVATION BIO INC | 66,666 | $178.0M | 0.02% | |
| 53 | —CEREVEL THERAPEUTICS HLDNG I | 33,333 | $144.0M | 0.01% |